| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| PORTNOY DAVID | Chairman, Co-CEO, Director, 10%+ Owner | 700 BROOKER CREEK BLVD, SUITE 1800, OLDSMAR | /s/ David Portnoy | 27 Aug 2025 | 0001315416 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CCEL | Common Stock | Purchase | $20,925 | +4,500 | +3.3% | $4.65 | 140,221 | 25 Aug 2025 | By 401K | |
| transaction | CCEL | Common Stock | Purchase | $23,250 | +5,000 | +3.6% | $4.65 | 145,221 | 25 Aug 2025 | By 401K | |
| transaction | CCEL | Common Stock | Purchase | $49,288 | +11,101 | +7.6% | $4.44 | 156,322 | 26 Aug 2025 | By 401K | F8 |
| transaction | CCEL | Common Stock | Purchase | $34,741 | +7,860 | +5% | $4.42 | 164,182 | 27 Aug 2025 | By 401K | F9 |
| transaction | CCEL | Common Stock | Purchase | $20,385 | +4,500 | +1.9% | $4.53 | 241,539 | 25 Aug 2025 | By IRA | F7 |
| transaction | CCEL | Common Stock | Purchase | $27,608 | +6,218 | +2.6% | $4.44 | 247,757 | 27 Aug 2025 | By IRA | |
| holding | CCEL | Common Stock | 804,742 | 25 Aug 2025 | Direct | ||||||
| holding | CCEL | Common Stock | 102,586 | 25 Aug 2025 | By Spouse | ||||||
| holding | CCEL | Common Stock | 59,027 | 25 Aug 2025 | By LLC | F5 | |||||
| holding | CCEL | Common Stock | 55,219 | 25 Aug 2025 | By Corporation | F6 | |||||
| holding | CCEL | Common Stock | 11,352 | 25 Aug 2025 | As Custodian for son | ||||||
| holding | CCEL | Common Stock | 11,242 | 25 Aug 2025 | As Custodian for son | ||||||
| holding | CCEL | Common Stock | 10,783 | 25 Aug 2025 | As Custodian for son | ||||||
| holding | CCEL | Common Stock | 15,611 | 25 Aug 2025 | As Custodian for daughter | ||||||
| holding | CCEL | Common Stock | 152,882 | 25 Aug 2025 | By Corporation | F10 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| holding | CCEL | Stock Option | 26,243 | 25 Aug 2025 | Common stock | 26,243 | $7.53 | Direct | ||||||
| holding | CCEL | Stock Option | 23,636 | 25 Aug 2025 | Common Stock | 23,636 | $7.28 | Direct | ||||||
| holding | CCEL | Stock Option | 280,000 | 25 Aug 2025 | Common Stock | 280,000 | $12.27 | Direct | F1 | |||||
| holding | CCEL | Stock Option | 50,000 | 25 Aug 2025 | Common Stock | 50,000 | $4.77 | Direct | F2 | |||||
| holding | CCEL | Stock Option | 50,000 | 25 Aug 2025 | Common Stock | 50,000 | $4.30 | Direct | ||||||
| holding | CCEL | Stock Option | 50,000 | 25 Aug 2025 | Common Stock | 50,000 | $6.47 | Direct | F3 | |||||
| holding | CCEL | Stock Option | 50,000 | 25 Aug 2025 | Common Stock | 50,000 | $8.08 | Direct | F4 |
| Id | Content |
|---|---|
| F1 | Stock options will vest immediately if the price of the Company's common stock reaches $25.00 per share during the seven-year option term. |
| F2 | 8,750 stock options vest upon issuance, 8,749 options vest on 1/2/2024, 21,000 options vest on 1/2/2025 and 11,501 options vest on 1/2/2026. |
| F3 | Stock options vest 1/3 upon issuance, 1/3 on December 22, 2024 and 1/3 on December 22, 2025. |
| F4 | Stock options vest 1/3 upon issuance, 1/3 on January 21, 2026 and 1/3 on January 21, 2027. |
| F5 | Shares of common stock held by Mayim Limited Partnership as is David Portnoy may be deemed the beneficial owner as the managing member and owner of Mayim Management, LLC, which is the general partner of Mayim Management Limited Partnership, which is the general partner of Mayim Investment Limited Partnership. |
| F6 | Shares of common stock held by uTIPu, Inc. as to which David Portnoy may be deemed the beneficial owner as the Chairman of the Board and Secretary. |
| F7 | The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.48 to $4.55, inclusive. The reporting person undertakes to provide to Cryo-Cell International, Inc. (the "Company"), any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. |
| F8 | The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.36 to $4.46, inclusive. The reporting person undertakes to provide to Cryo-Cell International, Inc. (the "Company"), any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. |
| F9 | The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.41 to $4.44, inclusive. The reporting person undertakes to provide to Cryo-Cell International, Inc. (the "Company"), any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. |
| F10 | Shares of Common Stock held by Partner Community, as to which David I. Portnoy may be deemed beneficial owner as the Chairman of the Board and Secretary. |